Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

China · Delayed Price · Currency is CNY

6.69

-0.21 (-3.04%)

Sep 30, 2026, 3:00 PM CST

Market Cap	7.30B +64.8%
Revenue (ttm)	2.63B -12.3%
Net Income	64.43M +58.2%
EPS	0.06 +60.8%
Shares Out	1.09B
PE Ratio	111.87
Forward PE	n/a
Dividend	0.05 (0.78%)
Ex-Dividend Date	Jul 14, 2026

Volume	219,135,889
Open	6.85
Previous Close	6.90
Day's Range	6.60 - 7.25
52-Week Range	3.68 - 8.44
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2026

About SHA:600488

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company’s primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, betamethasone product series, and other hormone precursors. The company provides amino acid raw materials, as well as preparations, including injections, ointments, creams, hard capsules, pills, freeze-dried powder inj... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1939

Employees 2,731

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600488

Full Company Profile

Financial Performance

In 2025, SHA:600488's revenue was 2.91 billion, a decrease of -9.56% compared to the previous year's 3.22 billion. Earnings were 70.56 million, a decrease of -47.12%.

Financial Statements